| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 01/26/2010 | US7652042 Compounds that abrogate DNA damage induced cell cycle G2 checkpoint and/or augment anti-cancer activity of DNA-damaging treatments |
| 01/26/2010 | US7652036 Carbamic acid compounds comprising a bicyclic heteroaryl group as HDAC inhibitors |
| 01/26/2010 | US7652031 Compounds which mimic the chemical and biological properties of discodermolide |
| 01/26/2010 | US7652022 N-(4-(4-(4-hydroxyphenylamino)-pyrimidin-6-yl)-oxyphenyl)-N'-(3-trifluoromethylphenyl)-urea; |
| 01/26/2010 | US7651999 2′, 5′-oligoadenylate analogs |
| 01/26/2010 | US7651998 administering a Venezuelan Equine Encephalitis (VEE) vector (alpha virus vector) comprising a heterologus nucleotide sequence to a subject; concurrently administering an antibody that specifically binds to the E1 and/or the E2 glycoprotein of the VEE vector to produce immune response to cancer patient |
| 01/26/2010 | US7651997 Deoxo-proline-containing tamandarin and didemnin analogs, dehydro-proline-containing tamandarin and didemnin analogs, and methods of making and using them |
| 01/26/2010 | US7651857 Inhibiting antigen presentation, comprising the step of supplying to an antigen-presenting cell, such as a dendritic cell, or precursor cell, a modulator, preferably an enhancer, of Toll-related receptor signalling |
| 01/26/2010 | US7651698 Prolonged release bioadhesive therapeutic systems |
| 01/26/2010 | US7651678 Methods to impair hematologic cancer progenitor cells and compounds related thereto |
| 01/26/2010 | CA2642066C Immuno-interactive fragments of the .alpha.c subunit of inhibin |
| 01/26/2010 | CA2555345C Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors |
| 01/26/2010 | CA2499354C Transcription control factor zhx3 |
| 01/26/2010 | CA2481012C Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors |
| 01/26/2010 | CA2470064C Triazolo-quinolin derivatives useful as adenosine receptor ligands |
| 01/26/2010 | CA2469380C Heteroaryl-substituted aminocyclohexane derivatives |
| 01/26/2010 | CA2465206C Polymeric thiol-linked prodrugs |
| 01/26/2010 | CA2456606C 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity |
| 01/26/2010 | CA2434731C Modular infusion device and method |
| 01/26/2010 | CA2421588C Tnf receptor-like molecules and uses thereof |
| 01/26/2010 | CA2408710C Compositions and methods for the treatment of colorectal cancer |
| 01/26/2010 | CA2393083C Use of hypoglycemic agent for treating impaired glucose metabolism |
| 01/26/2010 | CA2390263C Method for producing metabolites from plants cultivated in soil-less medium |
| 01/26/2010 | CA2350031C N-arylsulfonylamino acid omega-amides |
| 01/26/2010 | CA2349629C Methods for the production of tcr gamma delta t cells |
| 01/26/2010 | CA2328803C Anti-procalcitonin antibodies and the preparation and use thereof |
| 01/26/2010 | CA2303934C Tetrazole-containing rapamycin analogs with shortened half-lives |
| 01/26/2010 | CA2301499C T-cell membrane protein (tirc7), peptides and antibodies derived therefrom and uses thereof |
| 01/26/2010 | CA2275345C Pro-drugs and counterparts of camptothecin, their application as medicines |
| 01/26/2010 | CA2230086C Method to improve the biological and antiviral activity of protease inhibitors |
| 01/26/2010 | CA2222524C Somatostatin peptides |
| 01/26/2010 | CA2204666C Specific immunotherapy of cancer using a live recombinant bacterial vaccine vector |
| 01/21/2010 | WO2010009342A2 Inhibitors of bruton's tyrosine kinase for the treatment of solid tumors |
| 01/21/2010 | WO2010009285A1 Use of hdac inhibitors for the treatment of acute myeloid leukemia and/or myelodysplastic syndrome |
| 01/21/2010 | WO2010009280A1 Use of hdac inhibitors for the treatment of hodgkin's disease |
| 01/21/2010 | WO2010009183A1 Pyridone and pyridazone analogues as gpr119 modulators |
| 01/21/2010 | WO2010009155A2 Fused heterocyclyc inhibitor compounds |
| 01/21/2010 | WO2010009124A2 Anthracycline derivative conjugates, process for their preparation and their use as antitumor compounds |
| 01/21/2010 | WO2010008876A2 Method for preparation of micellar hybrid nanoparticles for therapeutic and diagnostic applications and compositions thereof |
| 01/21/2010 | WO2010008852A2 Methods of trea fing λλd methods of diagnosing an immunoproliferative disorder |
| 01/21/2010 | WO2010008843A1 Apoptosis signal-regulating kinase 1 inhibitors |
| 01/21/2010 | WO2010008744A2 Antineoplastic combinations containing hki-272 and vinorelbine |
| 01/21/2010 | WO2010008619A2 Extended release pharmaceutical formulations of s-adenosylmethionine |
| 01/21/2010 | WO2010008558A1 Compounds and methods of inducing apoptosis via interaction with chaperonin cct |
| 01/21/2010 | WO2010008554A2 Methods and products for treating proliferative diseases |
| 01/21/2010 | WO2010008528A2 Marek's disease virus vaccine compositions and methods of using thereof |
| 01/21/2010 | WO2010008454A1 Protein kinase inhibitors |
| 01/21/2010 | WO2010008263A1 Use of thalidomide to inhibit the osteoclast-activation process associated with multiple myeloma disease |
| 01/21/2010 | WO2010008075A1 Anti-system asc amino acid transporter 2 (asct2) antibody |
| 01/21/2010 | WO2010008069A1 Cell proliferation inhibitor |
| 01/21/2010 | WO2010008051A1 Anti-human clcp1 antibody and use thereof |
| 01/21/2010 | WO2010008001A1 Aptamer against il-17 and use thereof |
| 01/21/2010 | WO2010007972A1 Novel indole derivative having carbamoyl group, ureide group and substituted oxy group |
| 01/21/2010 | WO2010007800A1 Novel uracil compound having amide structure and salt thereof |
| 01/21/2010 | WO2010007756A1 Pyridine derivative having ttk inhibition activity |
| 01/21/2010 | WO2010007724A1 Peptide capable of binding to epcam |
| 01/21/2010 | WO2010007531A2 Use of defensin alpha 1 and/or defensin alpha 4, as a marker for predicting treatment response and/or a relapse in a patient suffering from chronic myeloid leukaemia |
| 01/21/2010 | WO2010007464A1 USE OF DEFENSIN α1 AND/OR DEFENSIN α4, AS A MARKER FOR PREDICTING A RELAPSE IN A PATIENT SUFFERING FROM CHRONIC MYELOID LEUKAEMIA |
| 01/21/2010 | WO2010007427A1 Pyrimidyl sulfonaminde derivative and its use for the treatment of chemokine mediated diseases |
| 01/21/2010 | WO2010007389A1 5 -amidothiazole derivatives and their use as checkpoint kinase inhibitors |
| 01/21/2010 | WO2010007374A1 Pharmaceutical compounds |
| 01/21/2010 | WO2010007318A2 Novel imidazo[1,2-a]pyrimidine derivatives, method for the preparation thereof, use thereof as medicaments, pharmaceutical compositions and novel use in particular as met inhibitors |
| 01/21/2010 | WO2010007317A1 Novel imidazo[1,2-a]pyridine derivatives, method for the preparation thereof, use thereof as medicaments, pharmaceutical compositions and novel use in particular as met inhibitors |
| 01/21/2010 | WO2010007316A2 Novel triazolo(4,3-a)pyridine derivatives, process for the preparation thereof, use thereof as medicaments, pharmaceutical compositions and novel use, in particular as met inhibitors |
| 01/21/2010 | WO2010007252A2 Formulation for improving the bioavailability of a hydrophobic molecule |
| 01/21/2010 | WO2010007248A2 Novel tricyclic derivatives, process for the preparation thereof and pharmaceutical compositions containing same |
| 01/21/2010 | WO2010007169A1 Pharmaceutical compositions comprising lignans and their derivatives for treating hyperplastic diseases |
| 01/21/2010 | WO2010007120A1 Pyridazine derivatives as smo inhibitors |
| 01/21/2010 | WO2010007116A2 New chemical compounds |
| 01/21/2010 | WO2010007114A2 New chemical compounds |
| 01/21/2010 | WO2010007100A1 7-substituted amino triazoles as pi3k inhibitors |
| 01/21/2010 | WO2010007099A1 2-aminoimidazo[1,2-b]pyridazine derivatives as pi3k inhibitors |
| 01/21/2010 | WO2010007027A1 Selective hydroxamic acid based mmp-12 and mmp-13 inhibitors |
| 01/21/2010 | WO2010007000A1 Cancerous disease modifying antibodies |
| 01/21/2010 | WO2010006982A1 Mimetics of sulfated oligosaccharides |
| 01/21/2010 | WO2010006755A2 A compound for imaging cell death |
| 01/21/2010 | WO2010006704A1 Oxazolopyrimidines as edg-1 receptor agonists |
| 01/21/2010 | WO2010006438A1 Thiosemicarbazone inhibitor compounds and cancer treatment methods |
| 01/21/2010 | WO2010006432A1 Pharmaceutical compositions comprising ret inhibitors and methods for the treatment of cancer |
| 01/21/2010 | WO2010006377A1 Therapeutic agents |
| 01/21/2010 | WO2010006376A1 Compositions comprising tea tree oil and methods for the prevention and treatment of cancer |
| 01/21/2010 | WO2009149279A3 Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
| 01/21/2010 | WO2009145489A3 Cell-permeable endostatin recombinant protein, a polynucleotide coated with the same, and an anti-cancer preparation containing the same as an active component |
| 01/21/2010 | WO2009134723A9 Progesterone antagonists such as cdb-4124 in the treatment of breast cancer |
| 01/21/2010 | WO2009128936A3 Compositions and methods for treating or preventing prostate cancer and for detecting androgen receptor variants |
| 01/21/2010 | WO2009124184A3 Azabenzanthrones for the treatment of viral infections, cancer or restenosis |
| 01/21/2010 | WO2009117706A3 Methods of treatment using anti-mif antibodies |
| 01/21/2010 | WO2009117116A3 Heat shock protein gp96 vaccination and methods of using same |
| 01/21/2010 | WO2009115927A3 Nucleotide analogues with quaternary carbon stereogenic centers and methods of use |
| 01/21/2010 | WO2009103741A3 Use of fsh receptor ligands for diagnosis and therapy of cancer |
| 01/21/2010 | WO2009067767A3 Targeted radiotherapy |
| 01/21/2010 | WO2009046841A8 Piperidine and piperazine derivatives for treating tumours |
| 01/21/2010 | WO2008116064A3 Fused heterocyclic compounds useful for the treatment of proliferative, allergic, autoimmune or inflammatory diseases |
| 01/21/2010 | WO2008083107A3 Combinations of antifolate agent and methoxyamine in the treatment of cancer |
| 01/21/2010 | WO2007041130A3 Deazapurines useful as inhibitors of janus kinases |
| 01/21/2010 | WO2002078642A9 Differentially-expressed and up-regulated polynucleotides and polypeptides in breast cancer |
| 01/21/2010 | US20100016938 Diagnosing, monitoring and treating inflammation |
| 01/21/2010 | US20100016783 Non-invasive systems and methods for in-situ photobiomodulation |
| 01/21/2010 | US20100016557 HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha |
| 01/21/2010 | US20100016445 Transdermal diethylstilbestrol for treating prostate cancer |